Immunity and immunization in elderly

Pathologie Biologie

Volumn 51, Issue 10, 2003, Pages 581-585

  Bourée, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Cell mediated immunity; Elderly; T lymphocytes; Tetanus

Indexed keywords

COTRIMOXAZOLE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS VACCINE; INFLUENZA VACCINE; INTERLEUKIN 2; ORAL ANTIDIABETIC AGENT; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; QUINOLONE DERIVATIVE; TETANUS TOXOID; THEOPHYLLINE; TYPHOID VACCINE; VACCINE; VARICELLA ZOSTER VACCINE;

B LYMPHOCYTE; BED NET; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CHICKENPOX; CYTOKINE PRODUCTION; DRUG POTENTIATION; ELDERLY CARE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNIZATION; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; LIFE EXPECTANCY; LYMPHOCYTE FUNCTION; MALARIA; MALNUTRITION; MORBIDITY; MORTALITY; PNEUMONIA; POLIOMYELITIS; PUBLIC HEALTH; RETIREMENT; REVIEW; SEROCONVERSION; STREPTOCOCCUS INFECTION; T LYMPHOCYTE; TETANUS; TETANUS PROPHYLAXIS; TRAVEL; TROPICS; TYPHOID FEVER; VACCINATION; VIRUS HEPATITIS;

EID: 0344413419     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2003.09.004     Document Type: Article

References (42)

1. Bourée P, Taugourdeau P. Voyages tropicaux des patients à risques. Dopamine, 2002 48 p.
2. Dessery BL, Robin MR, Pasini W. The aged, infirm, or handicapped traveler. In: Dupont HL, Steffen R, editors. Textbook of travel medicine and health. Ontario: Ed. Decker BC; 1997. p. 322-8.
3. Yan H, Kuroivwa A, Tanaka H, Shindo M, Kiyonaga A, Nagayama A. Effect of moderate exercise on immune senescence in men. Eur J App Physiol 2001;86:105-11.
4. Moulias R, Meaume S, Lesourd B. Vieillissement immunitaire et vieillissement de l'organisme chez l'homme. Acta Pharm Biol Clin 1995;8:131-40.
5. Lewis VM, Twomery JJ, Bealmear P, Goldstein G, Good RA. Age, thymic involution and circulating thymic hormone activity. J Clin Endocrinol Metabolism 1978;47:145-50.
6. Njemini R, Meyers I, Demanet C, Smitz J, Sosso M, Mets T. The prevalence of autoantibodies in an elderly sub-Saharan African population. Clin Exp Immunol 2002;127(1):99-106.
7. Ershler WB, Keller ET. Age-associated increased interleukin 6 gene expression late-life diseases and frailty. Ann Rev Med 2000;51:245-70.
8. Hamdi S, Aimeur N, Reingewirtz S, Amarenco P, Barthet C, Rajoely B. Les auto-anticorps anticardiolipine du sujet âgé: une conséquence du vieillissement? Acta Pharm Biol Clin 1995;8:249-53.
9. Proust JJ, Phelouzat MA, Quadri R, Arbogast A. Dysfonctionnement immunitaire lié à l'âge. Infect Immunol 1994;10:347-57.
10. Denis F, Ranger S, Mounier M. La réponse aux vaccinations chez le sujet âgé. Année Gérontol 1992:341-9.
11. Lesourd BM. Le vieillissement immunologique, influence de la dénutrition. Ann Biol Clin 1990;48:309-18.
12. Constans T, Alix E, Dardaine V. Malnutrition protéino-é nergétique: méthodes diagnostiques et épidémiologie. Presse Méd 2000;29(39): 2171-6.
13. Lesourd BM. Alimentation, nutrition et prévention en gériatrie. Général et Gérontol 1994;8:37-40.
14. Cederholm T, Jagren C, Hellström K. Outcome of protein-energy malnutrition in elderly medical patients. Am J Med 1995;98(1):67-74.
15. Mouc M, Bohmer T. Nutrition problems among home-living elderly people may lead to disease and hospitalization. Nutr Rev 1996;54: S22-4.
16. Raynaud-Simon A, Lesourd B. Dénutrition du sujet âgé: conséquences cliniques. Presse Méd 2000;29(39):2183-90.
17. Schwaiger S, Wolf AM, Robatscher P, Jenewein B, Grubeck-Loebenstein BJ. IL-4-producing CD8+T cells with a CD62L++ phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J Immunol 2003;170(1):613-9.
18. Wouters-Wesseling W, Rozendaal M, Snijder M, Graus Y, Rimmelzwaan G, De Groot L. Effect of a complete nutritional supplement on antibody response to influenza vaccine in elderly people. J Gerontol A Biol Sci Med Sci 2002;57(9):563-6.
19. Laporte PH, Gahbiche-Ghiloni J, Potaux C. Intérêt pronostique de l'albuminémie à l'admission en service de moyen séjour des sujets de plus de 75 ans: étude sur 205 cas. Age Nutr 1994;5(3):174-81.
20. Pavia M, Foresta MR, Carbone V, Angelillo IF. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes and practices among general practitioners in Italy. Public Health 2003; 117(3): 202-7.
21. Humair JP, Buchs CR, Stalder H. Promoting influenza vaccination of elderly patients in primary care. Fam Pract 2002;19(4):383-9.
22. Beyer WE, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: a review of literature. Vaccine 1989;7:385-94.
23. Michel JP, Gauthey L, Huang PY, Paccaud M, Grab B. Vaccination antigrippale au grand âge: cinq années de recherche appliquée. Méd Hyg 1991;49:3105-10.
24. Nichol KL, Goodman M. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine 2002; 20(Suppl 2):S21-4.
25. Gasparini R, Lucioni C, Lai P, Maggioni P, Sticchi L, Durando P. Cost benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria. Vaccine 2002;20(Suppl 5):B50-4.
26. Stein BE, Kligman EN. Vaccinations du sujet âgé. Gériatrie Contemp 1994;13:132-6.
27. Odelin MF, Momplot C, Bourlet T, Gonthier R, Aymard M, Pozzeto B. Temporal surveillance of the humoral immunity against influenza vaccine in the elderly over 9 consecutive years. Gerontology 2003; 49(4):233-9.
28. Gravenstein S, Davidson HE. Current strategies for management of influenza in the elderly population. Clin Infect Dis 2002;35(6):729-37.
29. Wang CS, Wang S, Chou P. Efficacy and cost effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine 2002;20(19-20):2494-9.
30. Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG. Cost effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Inter Med 2003;138(12):960-8.
31. Nierderman MS, editor. Respiratory infections in the elderly. New York: Raven Press; 1991.
32. Fedson D, Henrichsen J, Makela P, Austrian R. Immunization of elderly people with polyvalent pneumococcal vaccine. Infection 1989;17(6):437-41.
33. Zimmerman RK, Santibanez TA, Fine MJ, Janosky JE, Nowalk MP, Bardella IJ. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 2003;21(13-14):1510-7.
34. Prazuck T, Halioua B, Vincent-Bal Lereau F. Vaccination antipneumococcique. L'expérience américaine et la situation en France. Immunol Med 1992;9(4):1140-5.
35. Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 2003;16(2):308-18.
36. Loeb MB. Community-acquired pneumonia in older people: the need for a broader perspective. J Am Geriatr Soc 2003;51(4):539-43.
37. Wood RC, Mc Donald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota Health care workers. JAMA 1993;270(24):2935-9.
38. Briem H, Safary A. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. J Med Virol 1994;44:443-5.
39. Beytout J. Actualité de la prévention du tetanus. Conc Méd 1990; 112(11):973-8.
40. Antona D. Le tétanos en France en 2000 et 2001. Bull Epid Hebd 2002;40:197-9.
41. Pedalino B, Cotter B, Ciofidegli Atti M, Mandolini D, Parroccini S, Salmaso S. Epidemiology of tetanus in Italy in years 1971-2000. Euro Surveill 2002;7(7):103-10.
42. Hullstrung HD, Mausezahl D, Feuz M, Herzog C, Conzelmann M, Zimmerli W. Tetanus immunisation in geriatric patients with accidental wounds: how much is needed? Swiss Med Wkly 2003;133(15-16): 227-32.